High-Conviction Buys uncovers stocks that hedge funds have made significant new investments in relation to the size of portfolio. These stocks represent the best investment ideas that HedgeMind has handpicked based on a proprietary investment conviction indicator and our deep insight of hedge funds.
High-Conviction Buys is NOT simply a list of stock ideas, it is a showcase of a simple and rule-based strategy to invest alongside top performing managers.
ARRAY BIOPHARMA INC
Growth of $10K if invested alongside hedge fund manager
from 2016-06-10 to 2017-02-16
ARRY is one of winning stocks in High Conviction Buys. Past performance does not guarantee future results.
Rising Fund Ownership uncovers stocks that show the greatest percentage increase in total shares held by HedgeMind Core Managers in the latest quarter. In addition, stocks in the Rising Fund Ownership list must also show that institutional investors have increased buying.
1,919Return since 2018-08-15
SE is one of winning stocks in Rising Fund Ownership based on simulated results, which are not intended to represent actual results. Past performance does not guarantee future results.
Real-Time Trade Ideas are significant new positions that hedge funds have acquired recently and disclosed within 10 days of the last transaction. They represent the latest trade ideas that hedge funds have uncovered in the market now and are timely enough for investors to take a quick look and see if they are actionable trade opportunities.
Biotech Stocks to Watch highlights biotech stocks that hedge funds have recently either acquired as new or increased positions with shares greater than 5% of shares outstanding. They are new investment opportunities that hedge funds have found attractive at current valuations and are willing to put more new money to work. Two of the biggest biotech winners in the High-Conviction Buys, RARX and IMMU, were initially spotted in the Biotech Stocks to Watch list.
50 Matter Most Stocks are long equity positions that appear most frequently among the top 10 stock holdings within the portfolios of approximately 350 HedgeMind Core Managers. The screen is based on similar methodology that Goldman Sachs uses to construct its ETF GVIP.
Consensus Stock Picks shows maximum 100 stocks that are most commonly held among ~800 hedge funds. This stock screener makes it very easy for you to discover new stock ideas from the most popular stocks among different hedge fund groups such as hedge fund billionaires or very notable tiger cub hedge funds.